Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ammonia is a small nitrogenous molecule primarily produced in the gastrointestinal tract through the bacterial degradation of nitrogen-containing compounds and the hydrolysis of urea by microbial ureases (Source: PubChem, CID 222). In healthy physiology, gut-derived ammonia is transported via the portal vein to the liver, where it is converted into urea for renal excretion; however, in patients with cirrhosis or urea cycle disorders, this clearance mechanism fails, leading to systemic hyperammonemia (Source: StatPearls, NBK537209). Elevated ammonia levels are neurotoxic, as the molecule readily crosses the blood-brain barrier, causing astrocyte swelling and contributing to the clinical syndrome of hepatic encephalopathy (Source: J Clin Exp Hepatol, 2015). Therapeutic strategies target ammonia in the gut lumen to prevent its absorption, utilizing non-absorbable disaccharides like lactulose to acidify the environment and trap ammonia as ammonium ions (NH4+), or antibiotics like rifaximin to reduce the population of ammonia-producing bacteria (Source: LiverTox, NBK548059). Consequently, managing the gut ammonia pool is a fundamental approach to treating metabolic and neurological complications associated with liver failure.
Reduction of ammonia production by gut bacteria and acidification of the gut lumen to trap ammonia as non-absorbable ammonium ions.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ammonia (NH3) (NH3).